Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-24 @ 4:36 PM
NCT ID:
NCT06922266
Eligibility Criteria:
Inclusion Criteria:
* Participant is willing and able to provide informed consent for participation in the study.
* Age: Adults aged 18 years or older.
* Diagnosis: non-small cell lung cancer (Stage I-II, III), with or without lymph node involvement, ideally with sufficient tumor burden to provide adequate tissue for analysis. In accordance with good clinical practice, patients with early-stage disease will undergo direct surgery, whereas patients with advanced-stage disease will receive neoadjuvant treatment followed by surgery.
* Ability to attend scheduled follow-up visits, if applicable, for additional peripheral blood sample collection during treatment.
Exclusion Criteria:
* Presence of any active infection or underlying condition that could compromise the safety of tissue and blood sampling.
* Prior history of another malignancy that might interfere with data interpretation related to non-small cell lung cancer progression and immune response.
* Any current use of immunosuppressive medications (e.g., high-dose steroids) which might alter immune response assessments, except as part of non-small cell lung cancer treatment.
* Pregnancy and breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06922266
Study Brief:
Protocol Section:
NCT06922266